Look some of the worst things that an investor can do are being done by you. You have stated that you blindly follow Max and that you are riding everything on one stock. IF not AFFy you will soon lose all your money doing this. Don't be mistaken, having blind loyalty is not loyalty or any type of good feature, it is at its best being a lazy slob and having a prepared excuse. I have seen hundreds of times where someone professes their loyalty to a stock or person carping out unlimited garbage and loses everything.
First rule to understand about investing is no one knows for sure, so a balanced portfolio is essential. Every great investor makes #$%$ picks and if you bet a 100% on one of their bad picks it's still ends up being zero.
AFFY hinging on a binary event means no more than 5% of it should be in your account.
Take your loss while you can still get some money back, admit the mistake and commit yourself to learning how to invest using the rest, not being a sheep. After the recent 10Q ....??? In case it goes up, reduce it to what you can afford to lose 100% and play it like the lottery.
It made me a little more concerned, basically because it's hard for me to put the legalize in its proper context, but there was something that she, the neophyte wrote that is basically fraudulent. How can miss Mickey write that what QCOR is doing, by not posting all the active ingredients is illegal and that they will have to so generics will soon be able to steal the formula? Total #$%$ artist, no? QCOR is sponsoring research to figure out what's active. They couldn't if they were ordered to. Most everyone here knows that it's a strength that protects the drug.
As to the rest, it may have some insight but like I said I haven't sorted through enough similar situations or understand the legalize to say that investigation is revealing its nature because it referred to the present tense instead of using past tense.
Been saying that since it was 19. That would stabilize the stock more than anything. And they could find something accretive with a good pipeline.
The put options were at such a high price the only path for most is to figure out out how much they could afford to risk, that is assuming a 100% loss on the calls and buy no more. Deep in the money long term calls can cut some of the risk, but long term also means more money is at risk with giving up a lot of leverage. Calls were so expensive they were a lousy value.
Then again, how can investors not take one of the most transparent futures and bet on it? I can't say based on earnings that anyone who bet heavily on QCOR was wrong.
Just that we only rose 1.36 the next day after the downdraft. On a sixty dollar stock I can't really say that qualifies as any type of bounce
Good call 60. Anything more would be pretty damn ambitious even for shorts with this deep of pockets.
Since we didn't get the dead cat yesterday, maybe today? If there was one, it was insignificant.
That really bugged me that people were saying don't buy protection (even though I just about never do myself) especially before a binary event. I was going to go in the thread blistering the idea since some can lose everything during a cc on an interpretation. Especially calls.
Being that I suggested to someone that they had enough shares and not to toy with options since they were a newbie to options and suggested to someone else later that they move to a longer term option play for safety (which the market went up and at least in this case it worked in their favor staying with what they had) and also that I'm lazy I ended blowing it off. I should have taken time to explain in the first cases a safe or reasonable play and recently don't bet unless you're sure you can take the 100% loss.
Anyway the person who posted that they had bought 100 Nov 1 was maybe someone who people might have said something. Then again we don't need all this nanny stuff. Maybe it was a small bet.
Don't you ever sleep Mike?
I don't think I'd bet on that. Uncertainty is the worst killer on Wall Street. It's stench always seems to linger.
I've got calls I'm considering moving longer term, basically I was rich and one minute later I was crushed by something unfair, a nonevent backed by powerful deep pockets. Jo got lucky, but then the last thing to expect out of the market is any fairness.
The fact that we didn't see a deadcat today and that shorts brought it down precipitously every time it climbed doesn't bode well, but who knows. 1.36?
Here's what I would look for as a clue to when the mm's plan to move the stock up, another of those stupid reports that a buyout is on the way. Otherwise it may drift down until we see a catalyst. To make it at least immune from these attacks it needs to diversify and buy a company accretive to its earnings, but it sounds like they said 2015.
All medicine should be individualized. Most of what we are is proteins and many or most interactions in our body are controlled or caused by proteins. Bacteria produce a vast array of proteins and outlaw bacteria will produce different proteins from the normal flora. An outlaw taking over the colon is the reason for Monty Z's revenge. It was long theorized and already demonstrated that a return to the normal flora vs antibiotics which kept the normal flora from regenerating was a better approach, butt other than anal inspector who would want to give a shid suppository or shid oral pill considering the exp with things like Cholera and hygeine? hence the counterintuitive part.
It's not just experimental Johnny, it's a logical and important theoretical application not tried because it sounded counter intuitive, but has shown spectacular clinical results, in particular when patients are refractive to their medicines. And for this reason when a patient shows the symptoms of a disease, but usually effective medicines don't work, this can be another arrow in the quiver.
If a patient has mental disease it may be caused by proteins in the patient's gut as one example, another is weight gain, some flora of bacteria appear to produce proteins that mimic gherlen and others appear to produce proteins that can obstruct metabolism or promote fat being stored, etd.
Exactly, the CEO also communicated horribly on the channel stuffing incident allowing a short attack. Why anyone would laud his handling of this is beyond me.
Uniqueness of the product:
Well, it depends as Steve said from the experience that not only they are having with Acthar in treating dermatomyositis and polymyositisis, where they are seeing responses where Acthar patients have not been responsive to prior therapies. Additionally, many rheumatologists remember ATTH or Acthar from using it in the past for GALV, although that's not on the current indication. Rheumatologists do often remember that and quickly understand given their pretty strong background in immunology that they are connecting the dots that Acthar apparently has mechanisms that go beyond steroids.
Need for product, fills substantial void, specific niche with results that doctors find compelling:
So when they see the other indications as Steve mentioned, such as rheumatoid arthritis and lupus and they know that they have a large need for therapies, where patients have not done well on steroids or are not tolerating steroids although we have no data there yet and we can't – our reps are making any claims there. The doctors are adopting the drug on their own in those indications and getting good responses based on what I mentioned before about what they understand about the mechanism and their prior experiences in DMPM. So also we are able to support those indications with our patient assistance programs and knowing it available that they have a need, that they believe it will work and that we can support those from a reimbursement and distribution perspective. And also there is word is getting out among the rheumatology community. So there was information that are being shared and we are seeing an increase in demand there
Both of the following mean a ridiculously bright future for QCOR
How little penetration there is in the market:
Now, I will give a little more detail on each of these four shareholder value growth opportunities. First, Acthar sales are approaching $1 billion on an annual basis. Current sales are being generated from the use of Acthar to treat six approved medical conditions, nephritic syndrome, MS flares, dermatomyositis, polymyositis, infantile spasms, rheumatoid arthritis and lupus. With the exception of IS, we believe our penetration of our estimated addressable market for Acthar in each of these areas is less than 20% and well less than that in some of the newer areas. By comparison, market penetration for IS is likely over 40%.
On how effective and safe the drug is:
Yes, we have been hearing just as a little background, we have been hearing consistently positive overall anecdotal feedback on the clinical experience that rheumatologists have had since we feel that our sales force and we have sales folks educating doctors about all that. And it was nice to hear that firsthand at the ACR meeting. And I had the opportunity to speak with quite a few rheumatologists and the feedback continues to be just that, which is especially encouraging given that typically one of new drug like Acthar comes out and we enter these new markets, the drug is typically used in patients as a lifeline therapy and these are often some of the most difficult-to-treat patients. So I think that underscores the positive message there, the positive experience that we are hearing about good results even in these more typically more difficult-to-treat patients. And we are hearing that over a number of the indications that we have what doctors are using it in the rheumatology market.
A silly argument. He's always looking to incite a crowd for political purposes. HIgh prices of drugs are a thorn for most people. Easily a popular thing for him to obfuscate and create a crises and emotional hatred. No he doesn't know which companies, but he could care less when he tells his minions to go create a crises. QCOR was always in extra danger of being attacked by an Obama administration, it's his MO.
I'm sure he didn't know or care about the coal comapnies he's putting out of business either.
Not enough to screw the middle class out of their healthcare, destroy the best economy and healthcare in the world, he has to take attention off of his failures and mean spirited, incompetent administration. Coordinated-likely? What a creep he is.
He likely put four coal companies out of business already. Like I said at some point and time the administration will target QCOR.
Call me crazy but I loaded up stock after a Jo Kell sighting. Fashionably late in his short as always when he went all in at what I bet marked the low of AH. I couldn't get in an order fast enough.
I can't believe that this was at 70 for so long.